CIK: 0001388325 · Show all filings
Period: Q1 2015 (← Previous) (Next →)
Filing Date: May 15, 2015
Total Value ($000): $1,175,668 (98.3% shares, 1.7% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDS | 2,979,100 | $319,508 | 27.2% | $57.39 | — | TOTAL STK MKT | 922908769 |
| — | OPHTHOTECH CORP | 4,910,487 | $228,485 | 19.4% | $32.35 | — | COM | 683745103 |
| VGK | VANGUARD INTL EQUITY INDEX F | 2,101,000 | $113,916 | 9.7% | $45.01 | — | FTSE EUROPE ETF | 922042874 |
| INGN | INOGEN INC | 3,549,320 | $113,543 | 9.7% | $17.78 | +81.5% | COM | 45780L104 |
| — | NEVRO CORP | 2,194,841 | $105,199 | 8.9% | $38.67 | — | COM | 64157F103 |
| — | ALDER BIOPHARMACEUTICALS INC | 3,201,183 | $92,386 | 7.9% | $20.07 | — | COM | 014339105 |
| — | OTONOMY INC | 2,175,025 | $76,909 | 6.5% | $24.00 | — | COM | 68906L105 |
| — | FLEXION THERAPEUTICS INC | 2,283,131 | $51,416 | 4.4% | $17.27 | — | COM | 33938J106 |
| — | WRIGHT MED GROUP INC | 4,720,065 | $20,296 | 1.7% | $2.50 | — | RIGHT 03/01/2019 | 98235T115 |
| AKBA | AKEBIA THERAPEUTICS INC | 1,516,387 | $16,847 | 1.4% | $24.08 | -55.8% | COM | 00972D105 |
| — | TOKAI PHARMACEUTICALS INC | 1,184,196 | $13,381 | 1.1% | $14.46 | — | COM | 88907J107 |
| — | AERIE PHARMACEUTICALS INC | 419,652 | $13,152 | 1.1% | $29.19 | — | COM | 00771V108 |
| — | TETRAPHASE PHARMACEUTICALS INC | 231,419 | $8,479 | 0.7% | $23.73 | — | COM | 88165N105 |
| XENE | XENON PHARMACEUTICALS INC | 127,563 | $2,151 | 0.2% | $14.68 | +25.8% | COM | 98420N105 |